Literature DB >> 9782365

Coronary endothelial dysfunction increases the severity of ischaemia-induced ventricular arrhythmias in rat isolated perfused hearts.

Z F Hassanabad1, B L Furman, J R Parratt, E Aughey.   

Abstract

In order to determine the role of coronary vascular endothelial cells in generating cardioprotective substances during myocardial ischaemia, rat isolated hearts, perfused at constant flow by the Langendorff technique, were subjected to treatment with the detergent Triton X100 and the responses of these hearts to a 30 or 60 min period of coronary artery occlusion was determined. Endothelial damage or denudation was shown both by histological examination and by the altered vasodilator response to the endothelium-dependent vasodilator bradykinin (100 nM), which was reversed to vasoconstriction in hearts treated with Triton X-100. In contrast, the responses to sodium nitroprusside (100 microM) were unimpaired in these hearts and were not different from control responses. Ventricular ectopic activity was much more pronounced in hearts with endothelial dysfunction (e.g., 3329 +/- 361 ventricular premature beats over a 30 min occlusion period compared to 243 +/- 34 in controls; P < 0.01), and the duration of ventricular tachycardia was greatly increased (1162 +/- 391 s v 9 +/- 12 s in the controls; P < 0.01). Ventricular ectopic activity was still marked when the occlusion was prolonged to 1 h and was still apparent at the end of this 1 h occlusion period. Reperfusion arrhythmias (ventricular tachycardia and ventricular fibrillation) were marked in endothelium-damaged hearts (50%); whereas there were no such arrhythmias after a 30 or 60 min occlusion period in control hearts. Hearts were also preconditioned by a 3 min coronary artery occlusion period 10 min prior to a 30 min coronary artery occlusion. This reduced ventricular ectopic activity in both control and endothelium-damaged hearts to about the same extent (between 80 and 90% suppression). The results suggest that under normal conditions substances generated from endothelial cells protect the myocardium against ventricular arrhythmias both during ischaemia and reperfusion. However, in this species, preconditioning is still possible in hearts from which the coronary vascular endothelium has been removed. If these results can be extrapolated to the clinical situation, it suggests that in patients with endothelial dysfunction ventricular arrhythmias may be more pronounced following a period of ischaemia and especially of reperfusion.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9782365     DOI: 10.1007/s003950050091

Source DB:  PubMed          Journal:  Basic Res Cardiol        ISSN: 0300-8428            Impact factor:   17.165


  6 in total

Review 1.  Role of bradykinin in preconditioning and protection of the ischaemic myocardium.

Authors:  G F Baxter; Z Ebrahim
Journal:  Br J Pharmacol       Date:  2002-02       Impact factor: 8.739

2.  Decisions, directions, defects and fellow disciples (A rückblick of 50 years of basic medical research).

Authors:  James Roy Parratt
Journal:  Exp Clin Cardiol       Date:  2010

Review 3.  The endothelium: dysfunction and beyond.

Authors:  J Herrmann; A Lerman
Journal:  J Nucl Cardiol       Date:  2001 Mar-Apr       Impact factor: 5.952

Review 4.  Naturally Engineered Maturation of Cardiomyocytes.

Authors:  Gaetano J Scuderi; Jonathan Butcher
Journal:  Front Cell Dev Biol       Date:  2017-05-05

5.  Heart rate-adjusted PR as a prognostic marker of long-term ventricular arrhythmias and cardiac death in ICD/CRT-D recipients.

Authors:  Yu-Qiu Li; Shuang Zhao; Ke-Ping Chen; Yang-Gang Su; Wei Hua; Si-Lin Chen; Zhao-Guang Liang; Wei Xu; Yan Dai; Xiao-Han Fan; Shu Zhang
Journal:  J Geriatr Cardiol       Date:  2019-03       Impact factor: 3.327

6.  Influence of aging and chronic heart failure on temporal dispersion of myocardial repolarization.

Authors:  Gianfranco Piccirillo; Federica Moscucci; Matteo Pascucci; Maria Antonella Pappadà; Gaetana D'Alessandro; Pietro Rossi; Raffaele Quaglione; Daniele Di Barba; Francesco Barillà; Damiano Magrì
Journal:  Clin Interv Aging       Date:  2013-03-10       Impact factor: 4.458

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.